Xcout Intel
Kernal Biologics, Inc.
Kernal Biologics is an onco-selective mRNA therapeutics company located in Cambridge, Massachusetts, that creates mRNA therapies designed to instruct specific cells on how to make proteins.
Subscribe to see Kernal Biologics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Kernal Biologics, Inc. at a glance
Kernal Biologics, Inc. is a biotech company headquartered in United States. Its most recent funding round, Series A, raised $25M in July 2022. Xcout tracks 7 named people at Kernal Biologics, Inc., including Stephen DiPalma (Chief Financial Officer). Xcout recorded 7 job postings from Kernal Biologics, Inc. in the last 90 days.
Kernal Biologics, Inc. leadership
- Stephen DiPalmaChief Financial Officer
- Yusuf ErkulChief Executive Officer & Cofounder
- Burak YilmazPresident & Cofounder
- Jeff OzdemirHead of Platform & Cofounder
- Manfred KrausSVP, Head of R&D Therapeutics
- Balkrishen BhatHead of LNP Chemistry
1 more named person on record for Kernal Biologics, Inc., with roles, board committees and tenure — see the full roster →
Kernal Biologics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $25M | 4 named | |
| SEC Form D filing | $20.1M | — | |
| SEC Form D filing | $500,000 | — | |
| SEC Form D filing | $350,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Kernal Biologics, Inc.
Xcout recorded 7 job postings from Kernal Biologics, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Kernal Biologics, Inc.'s hiring signals →
Investors
Kernal Biologics, Inc. competitors
A few of Kernal Biologics, Inc.'s closest competitors — see the full list of competitors and alternatives →
CREATE Medicines is a clinical-stage biotechnology company located in Cambridge, Massachusetts, pioneering in vivo immune programming with RNA.
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
HelixNano is a biotechnology research company headquartered in Boston, Massachusetts, focused on developing advanced mRNA platform technologies for therapeutics.
BIND Therapeutics, Inc. is a clinical-stage nanomedicine company headquartered in Cambridge, Massachusetts. The company specializes in developing targeted and programmable therapeutics using its proprietary platform to treat various diseases.
Get Kernal Biologics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Kernal Biologics, Inc. in Xcout Intel
- 7 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access